Adjuvant Holdings Co.,Ltd. (4929.T)
Kobe, JP
Adjuvant Holdings Co.,Ltd. is a Japanese enterprise actively engaged in the entire process of cosmetics, from their research and development to their manufacturing and marketing within the nation. The company boasts a comprehensive catalog of products, encompassing a wide array of skincare items like cleansers, face washes, toners, serums, masks, hydrating creams, makeup bases, various makeup products, and body care formulations. Its hair care segment offers diverse solutions including shampoos, conditioners, scalp treatments, and styling aids, alongside other specialized products. Adjuvant Holdings predominantly serves professional establishments, such as hairdressing salons, barber shops, and beauty clinics. Established in 1990 with its headquarters in Kobe, Japan, the firm operated under the name Adjuvant Cosme Japan Co.,Ltd. until it officially adopted its current identity in September 2021.
Based on only 1 article — low confidence
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.14% | -0.81% | -1.88% | -10.51% | -4.06% | -4.19% | -3.56% | -20.35% | -28.24% | -20.86% | +25.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%-6.9% Q1'26: -18.4% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+251.6% ★ Q1'26: +10.6% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+3.7% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+4.5% Q1'26: -13.4% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+5.2% Q1'26: -13.3% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%-0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.08× ★ Q1'26: -0.08× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
|---|---|---|---|---|
| Revenue |
4.50B
est: 4.82B (-6.6%)
|
4.40B
est: 5.05B (-12.8%)
|
4.77B
est: 5.26B (-9.3%)
|
5.10B
est: 5.47B (-6.8%)
|
| EBITDA |
1.18B
est: 329.93M (+257.1%)
|
671.79M
est: 345.67M (+94.3%)
|
634.89M
est: 360.04M (+76.3%)
|
608.54M
est: 374.42M (+62.5%)
|
| EBIT |
733.91M
est: 205.70M (+256.8%)
|
594.10M
est: 215.51M (+175.7%)
|
539.52M
est: 224.48M (+140.3%)
|
511.26M
est: 233.44M (+119.0%)
|
| Net Income |
47.04M
est: 705.36M (-93.3%)
|
266.10M
est: 760.63M (-65.0%)
|
330.54M
est: 804.69M (-58.9%)
|
311.02M
est: 859.56M (-63.8%)
|
| SGA |
2.14B
est: 2.75B (-22.3%)
|
2.05B
est: 2.88B (-28.8%)
|
2.35B
est: 3.00B (-21.8%)
|
2.54B
est: 3.12B (-18.5%)
|
| EPS |
6.08
est: 88.05 (-93.1%)
|
33.83
est: 94.95 (-64.4%)
|
41.72
est: 100.45 (-58.5%)
|
39.32
est: 107.30 (-63.4%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-25 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Junko Tanaka | Senior MD & Director | — | — |
| Masaki Tanaka | Director | — | male |
| Takeshi Fujiwara | GM of Sales & Director | — | male |
| Yutaka Nakamura | Chairman & President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4929.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
